86 related articles for article (PubMed ID: 2303145)
1. Inhibition of ovulation with oral progestins--effectiveness in premenstrual syndrome.
West CP
Eur J Obstet Gynecol Reprod Biol; 1990; 34(1-2):119-28. PubMed ID: 2303145
[TBL] [Abstract][Full Text] [Related]
2. Treatment of severe premenstrual syndrome with oestradiol patches and cyclical oral norethisterone.
Watson NR; Studd JW; Savvas M; Garnett T; Baber RJ
Lancet; 1989 Sep; 2(8665):730-2. PubMed ID: 2570971
[TBL] [Abstract][Full Text] [Related]
3. Treatment of the premenstrual syndrome by subcutaneous estradiol implants and cyclical oral norethisterone: placebo controlled study.
Magos AL; Brincat M; Studd JW
Br Med J (Clin Res Ed); 1986 Jun; 292(6536):1629-33. PubMed ID: 3087550
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of severe premenstrual syndrome by combined use of gonadotropin-releasing hormone agonist and estrogen/progestin.
Mortola JF; Girton L; Fischer U
J Clin Endocrinol Metab; 1991 Feb; 72(2):252A-252F. PubMed ID: 1846868
[TBL] [Abstract][Full Text] [Related]
5. Elimination of ovulation and menstrual cyclicity (with danazol) improves dysphoric premenstrual syndromes.
Halbreich U; Rojansky N; Palter S
Fertil Steril; 1991 Dec; 56(6):1066-9. PubMed ID: 1743323
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the central effects of different progestins used in hormone replacement therapy.
Cagnacci A; Arangino S; Baldassari F; Alessandrini C; Landi S; Volpe A
Maturitas; 2004 Aug; 48(4):456-62. PubMed ID: 15283939
[TBL] [Abstract][Full Text] [Related]
7. A lecithin phosphatidylserine and phosphatidic acid complex (PAS) reduces symptoms of the premenstrual syndrome (PMS): Results of a randomized, placebo-controlled, double-blind clinical trial.
Schmidt K; Weber N; Steiner M; Meyer N; Dubberke A; Rutenberg D; Hellhammer J
Clin Nutr ESPEN; 2018 Apr; 24():22-30. PubMed ID: 29576358
[TBL] [Abstract][Full Text] [Related]
8. Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Premenstrual Syndrome Study Group.
Thys-Jacobs S; Starkey P; Bernstein D; Tian J
Am J Obstet Gynecol; 1998 Aug; 179(2):444-52. PubMed ID: 9731851
[TBL] [Abstract][Full Text] [Related]
9. Induced anovulation as treatment of premenstrual tension syndrome. A double-blind cross-over study with GnRH-agonist versus placebo.
Hammarbäck S; Bäckström T
Acta Obstet Gynecol Scand; 1988; 67(2):159-66. PubMed ID: 3140572
[TBL] [Abstract][Full Text] [Related]
10. Pyridoxine (vitamin B6) and the premenstrual syndrome: a randomized crossover trial.
Doll H; Brown S; Thurston A; Vessey M
J R Coll Gen Pract; 1989 Sep; 39(326):364-8. PubMed ID: 2558186
[TBL] [Abstract][Full Text] [Related]
11. Premenstrual tension: a placebo-controlled efficacy study with spironolactone and medroxyprogesterone acetate.
Hellberg D; Claesson B; Nilsson S
Int J Gynaecol Obstet; 1991 Mar; 34(3):243-8. PubMed ID: 1673942
[TBL] [Abstract][Full Text] [Related]
12. The effects of norethisterone in postmenopausal women on oestrogen replacement therapy: a model for the premenstrual syndrome.
Magos AL; Brewster E; Singh R; O'Dowd T; Brincat M; Studd JW
Br J Obstet Gynaecol; 1986 Dec; 93(12):1290-6. PubMed ID: 3801360
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, placebo-controlled, cross-over trial to assess the side effects of medroxyprogesterone acetate in hormone replacement therapy.
Kirkham C; Hahn PM; Van Vugt DA; Carmichael JA; Reid RL
Obstet Gynecol; 1991 Jul; 78(1):93-7. PubMed ID: 1828550
[TBL] [Abstract][Full Text] [Related]
14. Ovarian suppression with the gonadotrophin-releasing hormone agonist goserelin (Zoladex) in management of the premenstrual tension syndrome.
West CP; Hillier H
Hum Reprod; 1994 Jun; 9(6):1058-63. PubMed ID: 7962376
[TBL] [Abstract][Full Text] [Related]
15. A randomised comparison over 8 months of 100 micrograms and 200 micrograms twice weekly doses of transdermal oestradiol in the treatment of severe premenstrual syndrome.
Smith RN; Studd JW; Zamblera D; Holland EF
Br J Obstet Gynaecol; 1995 Jun; 102(6):475-84. PubMed ID: 7632640
[TBL] [Abstract][Full Text] [Related]
16. Negative mood changes during hormone replacement therapy: a comparison between two progestogens.
Björn I; Bixo M; Nöjd KS; Nyberg S; Bäckström T
Am J Obstet Gynecol; 2000 Dec; 183(6):1419-26. PubMed ID: 11120505
[TBL] [Abstract][Full Text] [Related]
17. The treatment of severe premenstrual syndrome with goserelin with and without 'add-back' estrogen therapy: a placebo-controlled study.
Leather AT; Studd JW; Watson NR; Holland EF
Gynecol Endocrinol; 1999 Feb; 13(1):48-55. PubMed ID: 10368798
[TBL] [Abstract][Full Text] [Related]
18. Treatment of premenstrual syndrome by spironolactone: a double-blind, placebo-controlled study.
Wang M; Hammarbäck S; Lindhe BA; Bäckström T
Acta Obstet Gynecol Scand; 1995 Nov; 74(10):803-8. PubMed ID: 8533564
[TBL] [Abstract][Full Text] [Related]
19. Randomized controlled trial of the management of premenstrual syndrome and premenstrual mastalgia using luteal phase-only danazol.
O'Brien PM; Abukhalil IE
Am J Obstet Gynecol; 1999 Jan; 180(1 Pt 1):18-23. PubMed ID: 9914571
[TBL] [Abstract][Full Text] [Related]
20. Ineffectiveness of progesterone suppository treatment for premenstrual syndrome.
Freeman E; Rickels K; Sondheimer SJ; Polansky M
JAMA; 1990 Jul; 264(3):349-53. PubMed ID: 2194047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
